Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No significant changes detected; the study record details, including title, design, eligibility criteria, interventions, outcomes, and locations, appear unchanged between the screenshots.
    Difference
    0.4%
    Check dated 2025-11-03T20:39:58.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:44:54.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.1.0; several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) were removed.
    Difference
    0.3%
    Check dated 2025-09-29T01:34:53.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:50:36.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.1%
    Check dated 2025-09-07T13:28:33.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of a facility name and location, as well as new content related to drug safety and various pharmaceutical compounds. Notably, acetylcysteine has been both added and removed, indicating a potential revision in its relevance or classification.
    Difference
    4%
    Check dated 2025-08-31T11:29:29.000Z thumbnail image

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.